ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Tea drinkers have lower glaucoma risk

Soy, cruciferous vegetables could help lower breast cancer treatment side effects

The Long-Term Benefits of Drinking Oolong Tea

Wonderful White Tea: A Drink Fit for an Emperor

Why You Should Try This Sweet-Smelling and Health-Boosting Essential Oil

Basic Aromatherapy to Help Balance and Calm

Arnica: This Powerful Herb Promotes Various Kinds of Healing

Chamomile Tea: Why This Ancient Therapeutic Drink Still Stands Out Today

Get ‘Hooked’ on Cat’s Claw: The Many Benefits of This Amazonian Herb

Try Apple Cider Vinegar and Black Cumin Oil as Your Go-To Salad Dressing

Print Page
Email Article

Orphan Medical Relies on PHT LogPad for Phase II Fibromyalgia Trial

  [ 413 votes ]   [ Discuss This Article ] • November 17, 2004

CHARLESTOWN, Mass.--(BUSINESS WIRE)--Nov. 17, 2004-

- Site acceptance, patient compliance, PHT study support already providing benefits early in study PHT Corporation, the leading provider of electronic patient reported outcome (ePRO) solutions used in over 130 trials worldwide, is pleased to announce that Orphan Medical has selected the LodPad(R) for its Phase II fibromyalgia trial. The study is being deployed across approximately 24 sites and 200 subjects throughout the United States and Canada.

First Patient In (FPI) occurred in June 2004, and Orphan Medical is very satisfied with the early results of the ePRO solution. Specifically, site acceptance and patient compliance are encouraging, and PHT's study support center has proven to be an effective service for Orphan as well. "We evaluated several vendors, and were assured by PHT's history of successful management and service that this would be replicated in pivotal trial for us," said Dr. Bill Houghton, Chief Scientific Officer at Orphan Medical. "The early results have justified our decision to date, as sites and subjects are responding well to the LogPad. Furthermore, PHT's study support center professionals have been highly efficient in responding to calls quickly and efficiently, enabling us to take full advantage of ePRO benefits right from the start of our trial."

The LogPad solution captures subject information relating to daily pain levels, daily fatigue symptoms and quality of sleep, as well as overall quality of life questions. "This is a very important trial for Orphan Medical, Inc., because it is the first clinical investigation outside of the narcolepsy indication," said Dr. Houghton. "Fibromyalgia is a condition that represents very significant unmet medical need, for there are no approved pharmacologic treatments, although there are several compounds under investigation at the present time.

Fibromyalgia represents a patient population that is much larger than the disease states we have studied to date, and therefore has great commercial significance to the Company. The data quality and the rigorous conduct of the clinical trial is of utmost importance to our assessment of the potential of Xyrem in this new indication." "We are pleased that Orphan is already realizing the valuable benefits it identified as critical success factors when selecting PHT as the eDiary vendor for this important trial," said Phil Lee, PHT President and CEO. "Orphan's work in central nervous system conditions is an example of an area of research that can greatly benefit from the advantages available with an eDiary and eSource system."

About Orphan Medical Orphan Medical acquires, develops, and markets pharmaceuticals of high medical value for inadequately treated and uncommon diseases treated by specialist physicians. Orphan Medical intends to build a strong presence in the sleep and central nervous system (CNS) markets. Orphan Medical's Internet Web site address is

About PHT Corporation PHT Corporation is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in over 130 trials worldwide. More than 50 biopharmaceutical and medical device companies, including 13 of the top 15 in the world, rely on PHT's innovative and comprehensive ePRO solutions for their Phase II, III and IV clinical studies. PHT's integrated Product Suite enables successful clinical trials by improving data quality, reducing data variance, and providing real-time access and analysis of the data collected. PHT leads the industry in experience with more than 70,000 subjects at 8,000 clinical sites in 45 countries and 34 languages around the globe. PHT, a pioneer in developing innovative technology to meet clinical research's evolving needs, is headquartered in Charlestown, MA, and Geneva, Switzerland. For more information, please visit LogPad and PHT are registered trademarks of PHT Corporation. (C) PHT Corporation

Post a Comment

Featured Products From the ProHealth Store
Vitamin D3 Extreme™ Ultra ATP+, Double Strength Energy NADH™ 12.5mg

Article Comments

Be the first to comment on this article!

Post a Comment

Optimized Curcumin Longvida with Omega-3

Featured Products

Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function

Natural Remedies

Red Yeast Rice - Natural Option for Supporting Healthy Cholesterol Red Yeast Rice - Natural Option for Supporting Healthy Cholesterol
Three-Step Strategy to Reverse Mitochondrial Aging Three-Step Strategy to Reverse Mitochondrial Aging
Green Coffee Extract: Unique Obesity Intervention Green Coffee Extract: Unique Obesity Intervention
More Weight Loss than Any Other Discovery in Supplement History More Weight Loss than Any Other Discovery in Supplement History
Repair Damaged Mitochondria and Reduce Fatigue Up to 45% Repair Damaged Mitochondria and Reduce Fatigue Up to 45%

ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
Credit Card Processing
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2018 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map